Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.

Carter NJ, Curran MP.

Drugs. 2011 Aug 20;71(12):1591-622. doi: 10.2165/11206860-000000000-00000. Review.

PMID:
21861544
2.

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, Wittes J.

JAMA. 1999 Jul 14;282(2):137-44.

PMID:
10411194
3.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
4.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
5.

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.

Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.

PMID:
19095024
6.

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.

Ambrose CS, Levin MJ, Belshe RB.

Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19. Review.

7.
8.

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.

Ambrose CS, Wu X, Knuf M, Wutzler P.

Vaccine. 2012 Jan 20;30(5):886-92. doi: 10.1016/j.vaccine.2011.11.104. Epub 2011 Dec 7.

9.

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.

Mallory RM, Yi T, Ambrose CS.

Vaccine. 2011 Jun 10;29(26):4322-7. doi: 10.1016/j.vaccine.2011.04.022. Epub 2011 Apr 20.

PMID:
21513761
10.

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

Belshe RB, Ambrose CS, Yi T.

Vaccine. 2008 Sep 12;26 Suppl 4:D10-6. doi: 10.1016/j.vaccine.2008.06.083.

PMID:
18611422
11.

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.

Ambrose CS, Dubovsky F, Yi T, Belshe RB, Ashkenazi S.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2549-57. Epub 2012 Mar 14.

12.

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.

Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM.

J Infect Dis. 2011 Nov 15;204(10):1475-82. doi: 10.1093/infdis/jir561. Epub 2011 Sep 23.

PMID:
21949042
13.

Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Andersohn F, Bornemann R, Damm O, Frank M, Mittendorf T, Theidel U.

GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.

14.

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Ambrose CS, Luke C, Coelingh K.

Influenza Other Respir Viruses. 2008 Nov;2(6):193-202. doi: 10.1111/j.1750-2659.2008.00056.x. Review.

15.

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.

Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.

Vaccine. 2011 Nov 21;29(50):9391-7. doi: 10.1016/j.vaccine.2011.09.109. Epub 2011 Oct 6.

PMID:
21983154
16.

Live attenuated influenza vaccine (Fluenz™): a guide to its use in the prevention of seasonal influenza in children in the EU.

Scott LJ, Carter NJ, Curran MP.

Paediatr Drugs. 2012 Aug 1;14(4):271-9. doi: 10.2165/11207080-000000000-00000.

PMID:
22702743
17.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
18.

Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.

Wang Z, Tobler S, Roayaei J, Eick A.

JAMA. 2009 Mar 4;301(9):945-53. doi: 10.1001/jama.2009.265. Epub 2009 Mar 2.

PMID:
19255113
19.

Live attenuated influenza virus vaccines: new options for the prevention of influenza.

Nichol KL.

Vaccine. 2001 Aug 14;19(31):4373-7. Review.

PMID:
11483261
20.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

Supplemental Content

Support Center